海洋细菌活性物质研究进展
Advances in the Bio-Active Products from Marine Bacteria—A Review
摘要: 海洋多变复杂的环境导致了海洋微生物的多样性。近几年的研究报道显示，占海洋微生物主导地位的海洋细菌产生的活性物质种类最为丰富，因此从海洋细菌中寻找新颖独特的具有药用价值的活性物质具有巨大潜力，海洋细菌也将成为新药筛选的重要资源，在药品开发中具有良好的发展前景。本文通过对近几年在海洋细菌活性物质研究这一领域研究论文的检索和归纳，对海洋细菌活性物质的主要特点和其在抑菌、抗肿瘤和酶及酶抑制剂、抗炎等多个方面的活性进行综述，揭示了海洋细菌活性物质在药物开发中的应用现状，总结了在这一领域现阶段所存在的问题，并对其未来的发展给予了展望。
Abstract: Ever-changing ocean environment has bred the extreme diversity of marine microorganisms. Recent re- searches showed that marine bacteria, the majority of the marine microorganism, generate abundant bio-active materials, indicating a foreseeable and great potential of the search for novel bio-active products from marine bacteria. This pro- gress has attracted attentions of both academia and business. Marine bacteria could become a new resource in drug screening and show a promising development prospect. Based on the recent works of bio-active material from marine bacteria, we reviewed their main features and active roles in the study of antibiotics, anti-tumor agents, enzyme and enzyme inhibitors, anti-inflammatory medicine and so on, revealing the current status of marine bacteria bio-active ma- terial in drug development. We summed up the problems encountered at this stage and made a prediction of probable hot spot in the future development.
文章引用：徐佰亮, 王莲芸. 海洋细菌活性物质研究进展[J]. 生物过程, 2012, 2(1): 7-12. http://dx.doi.org/10.12677/bp.2012.21002

参考文献

[1] R. V. Greene, H. L. Griffin and M. A. Cotta. Utility of alkaline protease from marine shipworm bacterium in industrial clean- sing applications. Biotechnology Letters, 1996, 18(7): 759-764.
[2] 林永成, 周世宁. 海洋微生物及其代谢产物[M]. 北京: 化学工业出版社, 2002.
[3] P. R. Burkholder, R. M. Pfister and F. M. Leitz. Production of a pyrrole antibiotic by a marine bacterium. Applied Microbiol- ogy, 1966, 14(4): 649-653.
[4] R. J. Amderson, M. S. Wolfe and D. Faulkner. Autotoxic antibi- otic production by a marine Chromobacterium. Marine Biology, 1974, 27: 281-285.
[5] I. H. Hardt, P. R. Jensen and W. Fenical. Nomarinone and new cytotoxic marinone derivatives, Produced by a marine filament- tous bacterium. Tetrahedr on Letters, 2000, 41(13): 2073-2076.
[6] U. Simidu, T. Noguchi, D. F. Hwang, Y. Shida, et al. Marine bacteria which produce tetrodotoxin. Applied and Environmental Microbiology, 1987, 53(7): 1714-1715.
[7] 池珍, 郑莺, 毛宁. 产河豚毒素(TTX)菌株ZY-23的分离与鉴定[J]. 微生物学通报, 2010, 37(2): 217-221.
[8] P. Sobik, J. Grunenberg, K. Böröczky, et al. Identification, syn- thesis, and conformation of tri- and tetrathiacycloalkanes from marine bacteria. Journal of Organic Chemistry, 2007, 72(10): 3776-3782.
[9] 王书锦, 胡江春, 薛德林. 中国黄、渤海、辽宁近海地区海洋微生物资源的研究[J]. 锦州师范学院学报, 2001, 22(1): 1-5.
[10] Z. Y. Li, Y. Hu, Y. Q. Huang, et al. Isolation and phylogenetic analysis of the biologically active bacteria associated with three South China Sea sponges. Microbiology, 2007, 76(4): 494-499.
[11] C. Jaruchoktaweechai, K. Suwanborirus and S. Tanasupawatt. New macrolactins from a marine Bacillus sp. Sc026. Nature Pro- duction Research, 2000, 63(7): 984-986.
[12] A. Raveh, S. Carmeli. Antimicrobial ambiguines from the cyano- bacterium Fischerella sp. collected in Israel. Nature Production Research, 2007, 70(2): 196-201.
[13] F. Fudou, T. Lizuka and S. Yamanaka. Haliangicin, a novel anti- fungal metabolite produced by a marine myxobacterium. The Journal of antibiotics, 2001, 54(2): 149-153.
[14] K. Yoshikawa, T. Takadera and K. Adachi. Korormicin, a noveI antibiotic specifically active against marine Gram-negative bac- teria, produced by a marine bacterium. The Journal of Antibiot- ics, 1997, 50(11): 949-953.
[15] L. M. Cañedo, J. L. Fernández-Puentes and J. P. Baz. IB-96212, a novel cytotoxic macrolide produced by a marine Micromono- spora. II. Physicochemical properties and structure determina- tion. The Journal of Antibiotics, 2000, 53(5): 479-483.
[16] 王凤平, 肖湘, 顾谦群等. 海洋来源细菌CB101抗肿瘤活性次级代谢产物的初步研究[A]. 2008年中国药学会学术年会暨第八届中国药师周论文集[C], 2008.
[17] M. Matsuda, T. Yamori and M. Naitoh. Structural revision of sulfated polysaccharide B-1 isolated from a marine Pseudomo- nas species and its cytotoxic activity against human cancer cell lines. MarBiotechnology, 2003, 5(1): 13-19.
[18] P. G. Wiliams, W. Y. Yoshida, M. K. Quon, et al. Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobac- terium Lyngbya sp. Journal of Natural Products, 2003, 66(5): 651-654.
[19] L. Zheng, X. Yan and X. Han. Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas pis- cicida and its apoptotic effect on cancer cells. Biotechnology and Applied Biochemistry, 2006, 44(3): 135-142.
[20] 吕家森, 黄惠琴, 丛明. 一株海洋细菌的鉴定及其活性物质的初步研究[J]. 海洋学报, 2006, 28(5): 173.
[21] 陈惠源, 蔡俊鹏, 刘江涛. 海洋细菌产琼胶酶的条件优化[J]. 现代食品科技, 2005, 21(3): 48-50.
[22] 徐庆强, 张志明, 王延明等. 产碱性纤维素酶海洋细菌的筛选、鉴定及酶学性质研究[J]. 海洋科学, 2009, 33(7): 1-5.
[23] 夏振强, 暴增海, 王增池等. 海洋细菌L1-9 菌株产蛋白酶发酵条件的优化[J]. 湖北农业科学, 2009, 48(5): 1129-1131.
[24] 张慧, 宁喜斌. 我国东海近海海域产胞外酶的海洋细菌的筛选[J]. 食品工业科技, 2008, 29(1): 121-123.
[25] 孙溢, 洪义国, 李勃. 海洋微生物低温酶特性及其在工业中的潜在用途[J]. 海洋水产研究, 2002, 23(3): 44-49.
[26] X. T. Fu, H. Lin and S. M. Kim. Purification and characteri- zation of a novelβ-agarase, AgaA34, from Agarivorans albus YKW-34. Applied Microbiology and Biotechnology, 2008, 11: 265-273.
[27] Y. Sugano, H. Nagae and K. Inagaki. Production and character- istics of some new β-agarases from a marine bacterium Vibrio sp. strain JT0107. Journal of Fermentation and Bioengineering, 1995, 79(6): 91-94.
[28] P. Shivanand, G. Jayaraman. Production of extracellular protease from halotolerant bacterium, Bacillus aquimarisstrain VITP4 isolated from Kumta coast. Process Biochemistry, 2009, 44(10): 1088-1094.
[29] R. Agrebi, A. Haddar, N. Hmidet, et al. BSF1 fibrinolytic en- zyme from a marine bacterium Bacillus subtilis A26: Purifica- tion, biochemical and molecular characterization. Process Bio- chemistry, 2009, 44(11): 1252-1259.
[30] B. K. Kim, B. H. Lee, Y. J. Lee, et al. Purification and charac- terization of carboxymethycellulase isolated from a marine bac- terium, Bacillus subtilis sub sp. Sbutilis A-53. Enzyme and Mi- crobial Technology, 2009, 44(6): 411-416.
[31] J. T. Woo, H. Ono and T. Tsuji. Cathestatins, new cysteine pro- tease inhibitors produced by Penicillium citrinum. Bioscience Biotechnology and Agrochemistry, 1995, 59(2): 350-352.
[32] S. Takaishi, N. Tuchiya, A. Sato, et al. B-90063, a Novel endo- thelin converting enzyme inhibitor isolated from a new marine bacterium, Blastobacter sp. SANK 71894. Journal of antibiot- ics, 1998, 51(9): 805-815.
[33] M. K. Renner, Y.-C. Shen, X.-C. Cheng, et al. Cyclomarins A-C, new antiinflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). Journal of the American Chemical Society, 1999, 121(49): 11273-11276.
[34] Z. D. Jiang, R. Paul. Lobophorins A and B, new anti-inflamma- tory macrolides produced by a tropical marine bacterium. Bio- organic and Medicinal Chemistry Letters, 1999, 9(14): 2003.
[35] L. T. Tan. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry, 2007, 68: 954-979.
[36] D. C. Oh, E. A. Gontang, C. A. Kauffman, et al. Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica. Journal of Natural Products, 2008, 71(4): 570-575.
[37] T. Nakashima, Y. Miyazaki, Y. Matsuyama, et al. Producing mechanism of an algicidal compound against red tide phyto- plankton in a marine bacterium γ-proteobacterium. Applied Mi- crobiology and Biotechnology, 2006, 73(3): 684-690.
[38] S. O. Lee, J. Kato, N. Takiguchi, et al. Involvement of an ex- tracellular protease in algicidal activity of the marine bacterium Pseudoalteromonas sp. strain A28. Applied and Environmental Microbiology, 2000, 66(10): 4334-4339.
[39] T. L. Zheng, J. Q. Su, K. Maskaoui, et al. Microbial modulation in the growth and toxin production of a redtide causing alga. Marine Pollution Bulletin, 2005, 51(8-12): 1018-1025.
[40] D. Sergey, X. Ying, et al. Antifouling diketopiperazines pro- duced by a deep sea bacterium. Streptomyces fungicidicus. Bio- fouling, 2006, 22(3): 201-208.